<DOC>
	<DOC>NCT00387309</DOC>
	<brief_summary>Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the investigational MOA-728 regimen than with a placebo regimen.</brief_summary>
	<brief_title>Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Inclusion: Must be scheduled for a segmental colectomy via open laparotomy with general anesthesia Subjects with history of inflammatory bowel disease are eligible as long as the disease is not currently active and all other criteria are met Subjects must meet the American Society of Anesthesiologists physical status I, II or III Exclusion: Subjects who are scheduled for laparoscopic surgery for the segmental colectomy Subjects with a recent history (&lt;1 year prior to randomization) of abdominal radiation therapy; Subjects with a history of small bowel obstruction, known or suspected bowel adhesions (other than minor, clinically nonsignificant adhesions) Subjects undergoing operations resulting in gastrointestinal ostomies, or who require use of post operative nonsteroidal antiinflammatory drugs (NSAIDs)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Bowel</keyword>
</DOC>